Bindarit inhibits human coronary artery smooth muscle cell proliferation, migration and phenotypic switching.

Bindarit, a selective inhibitor of monocyte chemotactic proteins (MCPs) synthesis, reduces neointimal formation in animal models of vascular injury and recently has been shown to inhibit in-stent late loss in a placebo-controlled phase II clinical trial. However, the mechanisms underlying the effica...

Full description

Saved in:
Bibliographic Details
Main Authors: Marcella Maddaluno, Gianluca Grassia, Maria Vittoria Di Lauro, Antonio Parisi, Francesco Maione, Carla Cicala, Daniele De Filippis, Teresa Iuvone, Angelo Guglielmotti, Pasquale Maffia, Nicola Mascolo, Armando Ialenti
Format: Artigo
Language:Inglês
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3471825?pdf=render
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items